Evaluation of the Effects of Treatment With Bioarginin C in Adult Subjects Belonging to the Post-Covid Day Hospital (BC)

University of Milan

Status: Unknown

Conditions: Fatigue Syndrome, Chronic; Inflammation

Treatments: Dietary Supplement: Bioarginina C

Study type: Interventional

Funder types: Other

Identifiers

NCT04947488

Bioarginina C

Details and patient eligibility

About

Long Covid could be much more frequent than it is thought to be. Few dwell on the great problem represented by the post covid syndrome. The virus often leaves important marks on our body, and those who recover face problems of various kinds: chronic fatigue, shortness of breath, dry cough, headache, cognitive difficulties.

On the duration and resolution of this syndrome, now recognized as a highly debilitating condition, there are still no great answers: for this reason it is always important to emphasize that contracting Covid, even in a not serious form, still means exposing oneself to long-term risks that are still not well codified by the scientific community. Guidelines and more tools are expected to best assist these patients.

Enrollment: 50 estimated patients

Sex: All

Ages: 20 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

subjects with proven positivity to the molecular test for Sars-cov2 with demonstration of microbiological healing patients discharged from FPG or other hospital structures; or only contact in PS; or home management age: range 20-60 years Fatigue operationalized as an affirmative answer to item "7" (CES-D)

Exclusion criteria

Pharmacological therapies with possible interactions with the mechanisms / processes under study (e.g. antihypertensive drugs, cortisone drugs, NSAIDs, immunosuppressants, nitrates)

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

50 participants in 2 patient groups, including a placebo group

Bioarginina C

Active Comparator group

Description:

vials based on L-arginine and liposomal vitamin C

Treatment:

Dietary Supplement: Bioarginina C

Placebo

Placebo Comparator group

Description:

vials without L-arginine and liposomal vitamin C

Treatment:

Dietary Supplement: Bioarginina C